Gen-Plus is a
small medium-sized, privately owned company. Its aim is to
discover innovations for contract partners. We design formulation
and technology concepts for the pharmaceutical
industry. This includes solid and semisolid dosage forms as well as
patches and thin films. The range is from the early idea to the
medicinal product samples (for clinical trials) under GMP
conditions. Another competence of us is consulting services for the
pharmaceutical industry.
In addition to NCE
formulations for Big Pharma, Gen-Plus creates innovative
design-arounds and Generics-plus concepts for established APIs.
There is also substantial number of OTC- and dietary
supplement-projects in the pipeline. Recently, Gen-Plus has started to
work on biotech molecules (non-parenteral) and liposomes.
In our laboratory
(area approximately 1000 m²) are currently 15 staff members
working in formulation and analytics. Special equipment
allows handling of high potent active pharmaceutical
ingredients. In addition, Gen-Plus has a comprehensive
quality management system and is licensed for handling of
narcotics.
We have
continuously invested in new technology e.g. Hot Melt Extrusion,
Lyophilization, Amorphization of APIs, Micro-/Nanoemulsions
etc.
Recent innovations
include alternative technologies based on Laser and
2D-/3D-Printing Technology respectively.
Gen-Plus is
closely linked to numerous national and international CROs and
universities. Thus, we offer to our customer access to the latest
technologies for scientific cooperation-projects.
We look forward to
finding - in close cooperation with you - solutions for your
complex challenges. Get in touch with our innovative team
and our broad-based laboratory.
You will get
inspired by many opportunities for innovation!